These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3811500)

  • 1. [Value of increased urinary excretion of modified nucleosides as tumor markers in colon cancer].
    Holstege A; Pauw M; Häring R; Kirchner R; Pausch J; Gerok W
    Verh Dtsch Ges Inn Med; 1986; 92():114-20. PubMed ID: 3811500
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
    Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
    Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
    Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
    Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of urinary immunosuppressive acidic protein in cancer patients].
    Hirayama T; Tamura K; Kikuchi S; Shibata Y; Kanno H; Sato Y; Ishida N; Kikuchi K
    Gan No Rinsho; 1983 Sep; 29(11):1323-9. PubMed ID: 6685196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
    Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
    Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
    Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
    Mao Y; Zhao X; Wang S; Cheng Y
    Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA; Grever MR; Speicher CE; Trewyn RW
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary modified nucleosides as tumor markers.
    Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
    Fischbein A; Sharma OK; Selikoff IJ; Borek E
    Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.
    Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC
    PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary levels of RNA catabolites in mice as early indicators for malignant growth.
    Thomale J; Luz A; Nass G
    Cancer Detect Prev; 1983; 6(1-2):73-6. PubMed ID: 6192923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
    Cho SH; Choi MH; Lee WY; Chung BC
    Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.